Barclays shares rally following COVID vaccine news
Barclays share price has rallied in recent weeks in the hope that COVID-19 vaccines will bring some normality back. Even with fortunes on the up, a recent government report has forced experts to take a bearish view on the bank.
Following what’s been a disastrous year for all banks, Barclays shares enjoyed an upswing in November. The promise of COVID-19 vaccines from Pfizer, Moderna, and others has buoyed markets across the board. The Barclays share price was up 40% by mid-November from 107p to 150p. Interest has since subsided, but shares remained above the November-low at 142p when trading began on 2 December.
Barclays shares buoyed by vaccine: but is it enough?
For what’s been a dire year, the late rally has generated some interest in Barclays prices. However, the Evening Standard’s Simon English has advised investors to ‘stay well back’ from banking shares. Even though he acknowledges the positive impact COVID-19 vaccines could have, the latest upswing, for him, means one of two things.
Either the market is in the ‘midst of a mini-rally’ and the ‘good times are around the corner’, or the bump has come and gone. In support of the former, banks enjoyed a fruitful third quarter (Q3). Looking at Barclays' Q3 report, group income was £16.8 billion. That’s a year-on-year (YoY) increase of 3%. Corporate and investment bank income was up 24%, taking group profit before tax to £2.4 billion. Even under tough operating conditions, Barclays has shown the group ‘remained profitable in each quarter’.
Taking a broader perspective on the Barclays share price, the current value is still lower than 2019’s peak. Tracking the data, Barclays shares reached 192p on 17 December 2019. Even at their best in 2020, the Barclays share price was 21% lower at 150p. Investec’s Ian Gordon has added to the bearish sentiment, suggesting that prolonged restrictions in the UK could hurt banking, moreover, Barclays. In his view, the ‘outlook remains problematic’.
Banking break-up could hamper Barclays share price recovery
British banks may also be facing political resistance on another front. Away from continued COVID restrictions, a recent APPG report could prompt changes across the industry at large. A two-year inquiry into competition within the UK banking sector has revealed ‘poor practices’ and ‘predatory pricing models’.
The news comes as challenger bank Monzo launched its third new account and gained more account switches than any other UK bank in November. The APPG report has called for a ‘break-up’ ‘demerger’ of the major banks, including Barclays. Whether or not this comes to pass is anyone’s guess.
The Competitions and Markets Authority (CMA) proposed a similar strategy in 2016. However, what’s clear is that conditions are ripe for change. COVID-19 has stretched the market and, even when life returns to normal, it may not be the 'normal' we remember. Barclays shares have rallied, which has generated some buzz. However, experts remain cautious and can’t seem to find a reason to break their bearish forecasts.
Are Barclays shares an attractive price to trade right now?
For just a small initial deposit, you can speculate on the Barclays share price with spread bets or CFDs. Spread bets are completely tax-free, while CFDs are free from stamp duty.1 You can also buy and take ownership of UK shares for just £3 with us.2
Open an account to start trading or investing in UK shares.
1 Tax laws are subject to change and depend on individual circumstances. Tax law may differ in a jurisdiction other than the UK.
2 Deal three times or more in the previous month to qualify for our best rate.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Act on share opportunities today
Go long or short on thousands of international stocks with spread bets and CFDs.
- Get full exposure for a comparatively small deposit
- Trade on spreads from just 0.1%
- Get greater order book visibility with direct market access
See opportunity on a stock?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Take your position
- See whether your hunch pays off
See opportunity on a stock?
Don’t miss your chance – upgrade to a live account to take advantage.
- Trade a huge range of popular stocks
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See opportunity on a stock?
Don’t miss your chance. Log in to take advantage while conditions prevail.
Live prices on most popular markets
You might be interested in…
Find out what charges your trades could incur with our transparent fee structure.
Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.
Stay on top of upcoming market-moving events with our customisable economic calendar.